Physician profile
Marcus A Jones
NPI 1326226127
$5,719.37
in general payments reported to CMS, 2019-2025
22 companies · $1,334 in 2025
The $1,334 reported for 2025 was more than what 87% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $576 · 2023: $2,763 · 2024: $891 · 2025: $1,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,054 · Travel and Lodging: $1,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,053.64 |
| Travel and Lodging | $1,934.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,479.10 | 2021-2024 | Indigo System, Ruby Coil |
| Asahi Intecc USA, INC. | $659.67 | 2023-2025 | Asahi Interventional Radiology Wires, Peripheral Vascular, Asahi Peripheral Vascular Wires |
| Boston Scientific Corporation | $356.67 | 2022-2023 | Embold Fibered |
| Medtronic, INC. | $279.10 | 2021-2024 | Osteocool Rf Ablation System, Concertotm |
| W. L. Gore & Associates, INC. | $245.13 | 2022 | |
| Dendreon Pharmaceuticals LLC | $218.44 | 2024-2025 | Provenge |
| Terumo Medical Corporation | $204.99 | 2022-2024 | Azur Cx Detachable, Hydropearl, Navicross |
| Sumitomo Pharma America, INC. | $202.56 | 2024-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $189.66 | 2024 | Aquabeam System |
| Janssen Biotech, INC. | $172.30 | 2024-2025 | Rybrevant, Carvykti, Erleada |
| Urogen Pharma, INC. | $171.57 | 2025 | |
| Inari Medical, INC. | $159.94 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Olympus America INC. | $129.39 | 2023 | Itind System |
| Ferring Pharmaceuticals INC. | $61.80 | 2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $38.13 | 2024-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $33.65 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $23.57 | 2025 | |
| Endo USA, INC. | $20.60 | 2025 | Aveed, Xiaflex |
| Novartis Pharmaceuticals Corporation | $20.33 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $19.35 | 2025 | |
| Telix Pharmaceuticals | $18.19 | 2025 | Illuccix |
| Abbvie INC. | $15.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.